GlassScriptPhysician profile
Roger W Werth
NPI 1245216118
$376.55
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $64.19 · 2021: $31.61 · 2022: $26.82 · 2023: $79.75 · 2024: $48.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $44.54 | 2019 | |
| Innovation Technologies INC | $42.86 | 2020 | |
| Polynovo North America LLC | $32.28 | 2024 | Novosorb Btm |
| Atricure, INC. | $28.58 | 2023 | |
| Smith+Nephew, INC. | $27.40 | 2019 | |
| Mozarc Medical US LLC | $25.98 | 2023 | Chameleon |
| Merit Medical Systems INC | $25.19 | 2023 | Savi Scout |
| Merck Sharp & Dohme LLC | $24.25 | 2019 | |
| Endogastric Solutions, INC | $21.33 | 2020 | |
| Csl Behring | $19.80 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.77 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.50 | 2024 | Voquezna |
| Organogenesis INC. | $15.79 | 2022 | |
| Davol INC. | $12.44 | 2019 | |
| Integra Lifesciences Corporation | $11.81 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $11.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Werth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.